Equities
Health CareMedical Equipment and Services
  • Price (USD)72.54
  • Today's Change-1.80 / -2.42%
  • Shares traded4.17m
  • 1 Year change-26.24%
  • Beta1.1120
Data delayed at least 15 minutes, as of Nov 13 2024 20:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Dexcom Inc grew revenues 24.49% from 2.91bn to 3.62bn while net income improved 58.70% from 341.20m to 541.50m.
Gross margin62.10%
Net profit margin17.22%
Operating margin15.88%
Return on assets10.51%
Return on equity32.06%
Return on investment14.28%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Dexcom Inc fell by 75.80m. However, the company earned 748.50m from its operations for a Cash Flow Margin of 20.66%. In addition the company used 507.20m on investing activities and also paid 318.60m in financing cash flows.
Cash flow per share2.15
Price/Cash flow per share32.51
Book value per share5.07
Tangible book value per share4.73
More ▼

Balance sheet in USDView more

Dexcom Inc has a Debt to Total Capital ratio of 55.79%, a lower figure than the previous year's 109.81%.
Current ratio2.46
Quick ratio2.12
Total debt/total equity1.26
Total debt/total capital0.5579
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 59.45%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
85.53
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.